Effectiveness of BNT162b2 and CoronaVac vaccinations against SARS-CoV-2 omicron infection in people aged 60 years or above: a case-control study.

Eric Yuk Fai WanAnna Hoi Ying MokVincent Ka Chun YanCheyenne I Ying ChanBoyuan WangFrancisco Tsz Tsun LaiCeline Sze Ling ChuiXue LiCarlos King-Ho WongChak Sing LauIan Chi Kei WongEsther Wai Yin Chan

Published in: Journal of travel medicine (2022)

Both BNT162b2 and CoronaVac vaccination were effective in protecting older adults against COVID-19 infection and COVID-19-related severe outcomes amidst the Omicron BA.2 pandemic, and VE increased further with the third dose.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
randomized controlled trial
physical activity
systematic review
early onset
drug induced
adipose tissue
skeletal muscle